XML 45 R32.htm IDEA: XBRL DOCUMENT v3.23.3
Equity-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Summary Of The Restricted Stock
SHARESWEIGHTED-
AVERAGE
GRANT DATE
FAIR VALUE
Non-vested restricted stock as of December 31, 20221,402,813$23.27 
Granted— — 
Vested*(600,016)23.28 
Forfeited(135,618)23.00 
Non-vested restricted stock as of September 30, 2023667,179$23.32 
Summary Of The Company's RSU activity
A summary of the Company’s RSU activity is as follows:
UNITSWEIGHTED-
AVERAGE
GRANT DATE
FAIR VALUE
Non-vested RSUs as of December 31, 20222,005,095$24.71 
Granted*1,626,10223.93 
Vested**(796,494)25.24 
Forfeited(304,923)23.52 
Non-vested RSUs as of September 30, 20232,529,780$24.18 
___________________________________
*The majority shares granted during 2023 were issued on April 1, 2023 under the 2020 Incentive Plan.
**The number of the RSUs vested includes 275,516 shares that were withheld on behalf of employees to satisfy the statutory tax withholding requirements. The vested shares included 9,324 shares vested but deferred in connection with our director deferral plan.
Schedule Of Nonvested Performance-Based Units Activity
UNITS WEIGHTED-
AVERAGE
GRANT DATE
FAIR VALUE
Non-vested PSUs as of December 31, 2022654,308$23.99 
Granted484,88527.00 
Vested(18,437)24.83 
Forfeited(94,054)25.71 
Non-vested PSUs as of September 30, 20231,026,702$25.24 
Schedule Of Compensation Expense
The following table summarizes the components of total equity-based compensation expense included in the condensed consolidated statements of operations and comprehensive income (loss) for each period presented:
THREE MONTHS ENDED SEPTEMBER 30,NINE MONTHS ENDED SEPTEMBER 30,
2023202220232022
(In thousands)
Cost of revenues$3,198 $2,454 $8,328 $6,834 
Sales and marketing343 160 1,272 1,670 
Research and development1,919 957 4,789 4,115 
General and administrative 3,185 3,233 6,409 11,199 
Total$8,645 $6,804 $20,798 $23,818